• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄、多种慢性疾病与 COVID-19:文献回顾。

Age, Multiple Chronic Conditions, and COVID-19: A Literature Review.

机构信息

Meyers Primary Care Institute, Worcester, Massachusetts, USA.

Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester, USA.

出版信息

J Gerontol A Biol Sci Med Sci. 2022 Apr 1;77(4):872-878. doi: 10.1093/gerona/glaa320.

DOI:10.1093/gerona/glaa320
PMID:33367606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7799222/
Abstract

BACKGROUND

Various patient demographic and clinical characteristics have been associated with poor outcomes for individuals with coronavirus disease 2019 (COVID-19). To describe the importance of age and chronic conditions in predicting COVID-19-related outcomes.

METHODS

Search strategies were conducted in PubMed/MEDLINE. Daily alerts were created.

RESULTS

A total of 28 studies met our inclusion criteria. Studies varied broadly in sample size (n = 21 to more than 17,000,000). Participants' mean age ranged from 48 years to 80 years, and the proportion of male participants ranged from 44% to 82%. The most prevalent underlying conditions in patients with COVID-19 were hypertension (range: 15%-69%), diabetes (8%-40%), cardiovascular disease (CVD) (4%-61%), chronic pulmonary disease (1%-33%), and chronic kidney disease (range 1%-48%). These conditions were each associated with an increased in-hospital case fatality rate (CFR) ranging from 1% to 56%. Overall, older adults have a substantially higher case fatality rate (CFR) as compared to younger individuals affected by COVID-19 (42% for those <65 vs 65% > 65 years). Only one study examined the association of chronic conditions and the risk of dying across different age groups; their findings suggested similar trends of increased risk in those < 65 years and those > 65 years as compared to those without these conditions.

CONCLUSIONS

There has been a traditional, single-condition approach to consideration of how chronic conditions and advancing age relate to COVID-19 outcomes. A more complete picture of the impact of burden of multimorbidity and advancing patient age is needed.

摘要

背景

各种患者人口统计学和临床特征与患有 2019 年冠状病毒病(COVID-19)的个体的不良结局相关。描述年龄和慢性疾病在预测 COVID-19 相关结局中的重要性。

方法

在 PubMed/MEDLINE 中进行了检索策略。创建了每日警报。

结果

共有 28 项研究符合我们的纳入标准。研究在样本量上差异很大(n = 21 至超过 1700 万)。参与者的平均年龄从 48 岁到 80 岁不等,男性参与者的比例从 44%到 82%不等。COVID-19 患者中最常见的基础疾病是高血压(范围:15%-69%)、糖尿病(8%-40%)、心血管疾病(CVD)(4%-61%)、慢性肺病(1%-33%)和慢性肾脏病(范围 1%-48%)。这些疾病与住院病死率(CFR)的增加相关,范围从 1%到 56%不等。总体而言,与 COVID-19 相关的较年轻患者相比,老年患者的病死率(CFR)明显更高(<65 岁的患者为 42%,>65 岁的患者为 65%)。只有一项研究检查了慢性疾病与不同年龄组死亡风险之间的关联;他们的研究结果表明,与没有这些疾病的患者相比,<65 岁和>65 岁的患者的风险增加趋势相似。

结论

传统上,对于慢性疾病和年龄增长如何与 COVID-19 结局相关,采用了单一疾病的方法进行考虑。需要更全面地了解多种合并症的负担和患者年龄增长对 COVID-19 结局的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94fd/8974330/bef98af586b4/glaa320f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94fd/8974330/1b9ea59057c0/glaa320f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94fd/8974330/bef98af586b4/glaa320f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94fd/8974330/1b9ea59057c0/glaa320f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94fd/8974330/bef98af586b4/glaa320f0002.jpg

相似文献

1
Age, Multiple Chronic Conditions, and COVID-19: A Literature Review.年龄、多种慢性疾病与 COVID-19:文献回顾。
J Gerontol A Biol Sci Med Sci. 2022 Apr 1;77(4):872-878. doi: 10.1093/gerona/glaa320.
2
Patterns of multimorbidity and risk of severe SARS-CoV-2 infection: an observational study in the U.K.多病症模式与严重 SARS-CoV-2 感染风险:英国的一项观察性研究
BMC Infect Dis. 2021 Sep 4;21(1):908. doi: 10.1186/s12879-021-06600-y.
3
The association between patients' frailty status, multimorbidity, and demographic characteristics and changes in primary care for chronic conditions during the COVID-19 pandemic: a pre-post study.COVID-19 大流行期间,患者衰弱状况、多种并存疾病以及人口统计学特征与慢性病初级保健变化之间的关联:一项前后研究。
Fam Pract. 2023 Nov 23;40(4):523-530. doi: 10.1093/fampra/cmad089.
4
The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis.20205 例新冠病毒感染患者中慢性合并症的流行病学负担和总体分布:系统评价和荟萃分析的证据。
Infection. 2020 Dec;48(6):813-833. doi: 10.1007/s15010-020-01502-8. Epub 2020 Aug 19.
5
Older adults with non-communicable chronic conditions and their health care access amid COVID-19 pandemic in Bangladesh: Findings from a cross-sectional study.孟加拉国 COVID-19 大流行期间患有非传染性慢性病的老年人及其获得医疗保健的情况:一项横断面研究的结果。
PLoS One. 2021 Jul 29;16(7):e0255534. doi: 10.1371/journal.pone.0255534. eCollection 2021.
6
Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.糖尿病和心血管疾病在孟加拉国新冠肺炎患者中的患病率及其对临床结局的影响。
Diabetes Metab Syndr. 2021 May-Jun;15(3):1009-1016. doi: 10.1016/j.dsx.2021.05.005. Epub 2021 May 8.
7
Managing Multimorbidity (Multiple Chronic Diseases) Amid COVID-19 Pandemic: A Community Based Study From Odisha, India.管理 COVID-19 大流行期间的多种合并症(多种慢性病):来自印度奥里萨邦的一项社区研究。
Front Public Health. 2021 Feb 1;8:584408. doi: 10.3389/fpubh.2020.584408. eCollection 2020.
8
Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.1 型和 2 型糖尿病患者 COVID-19 病死率的危险因素:俄罗斯联邦 235248 例患者的全国回顾性队列研究。
Front Endocrinol (Lausanne). 2022 Aug 9;13:909874. doi: 10.3389/fendo.2022.909874. eCollection 2022.
9
Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.斋浦尔市522例COVID-19住院患者的羟氯喹特性、治疗结果及作用:一项流行病学临床研究
J Assoc Physicians India. 2020 Jun;68(6):13-19.
10
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.年龄和多种合并症预测 COVID-19 患者的死亡:意大利高血压学会 SARS-RAS 研究的结果。
Hypertension. 2020 Aug;76(2):366-372. doi: 10.1161/HYPERTENSIONAHA.120.15324. Epub 2020 Jun 22.

引用本文的文献

1
Retrospective Analysis of Factors Associated with a Prolonged Nucleic Acid Conversion Time in Patients with COVID-19 at Fangcang Shelter Hospital.方舱医院新冠肺炎患者核酸转阴时间延长相关因素的回顾性分析
Infect Drug Resist. 2025 Jun 30;18:3219-3229. doi: 10.2147/IDR.S521808. eCollection 2025.
2
Impaired Cytokine Secretion Contributes to Age-Dependent Immune Dysfunction in SARS Coronavirus Response and Is Restored by Young CD11b-Positive Cell Transfer.细胞因子分泌受损导致严重急性呼吸综合征冠状病毒反应中年龄依赖性免疫功能障碍,并可通过年轻的CD11b阳性细胞转移得以恢复。
Aging Cell. 2025 Sep;24(9):e70154. doi: 10.1111/acel.70154. Epub 2025 Jun 29.
3

本文引用的文献

1
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.美国 31461 例 COVID-19 成年人死亡相关合并症:一项联合电子病历分析。
PLoS Med. 2020 Sep 10;17(9):e1003321. doi: 10.1371/journal.pmed.1003321. eCollection 2020 Sep.
2
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization.肥胖与新冠肺炎确诊患者的死亡率:来自一体化医疗保健组织的研究结果。
Ann Intern Med. 2020 Nov 17;173(10):773-781. doi: 10.7326/M20-3742. Epub 2020 Aug 12.
3
Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort.
A retrospective cohort study of the efficacy and safety of oral azvudine nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 years.
一项关于口服阿兹夫定联合奈玛特韦/利托那韦治疗60岁以上老年住院COVID-19患者疗效和安全性的回顾性队列研究。
Acta Pharm Sin B. 2025 Mar;15(3):1333-1343. doi: 10.1016/j.apsb.2024.12.032. Epub 2024 Dec 31.
4
The health care needs of multidimensional frail elderly patients with multimorbidity in primary health-care settings: a qualitative study.基层医疗卫生机构中患有多种疾病的多维体弱老年患者的医疗保健需求:一项定性研究。
BMC Prim Care. 2025 Apr 25;26(1):128. doi: 10.1186/s12875-025-02836-8.
5
Minority health social vulnerability index and long COVID illness among a statewide, population-based study of adults with polymerase chain reaction-confirmed SARS-CoV-2.在一项基于全州人口的、针对经聚合酶链反应确诊感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的成年人的研究中,少数族裔健康社会脆弱性指数与新冠长期症状
Arch Public Health. 2025 Mar 10;83(1):64. doi: 10.1186/s13690-025-01553-z.
6
Reduced functional independence and multimorbidity increases the risk of severe infection among older patients with Omicron: a multicenter retrospective cohort study.功能独立性降低和多种疾病并存增加了感染奥密克戎的老年患者发生严重感染的风险:一项多中心回顾性队列研究。
BMC Geriatr. 2025 Feb 6;25(1):84. doi: 10.1186/s12877-025-05739-6.
7
The Severity of the COVID-19 Among Chronic Disease Patients in the Selected Hospitals in Riyadh, Saudi Arabia - A Retrospective Study.沙特阿拉伯利雅得选定医院中慢性病患者的 COVID-19 严重程度——一项回顾性研究
Risk Manag Healthc Policy. 2024 Dec 27;17:3327-3339. doi: 10.2147/RMHP.S456155. eCollection 2024.
8
Analysis of COPD: Distinguishing Characteristics and Management of Smoking vs Never Smoking Patients.慢性阻塞性肺疾病分析:吸烟患者与从不吸烟患者的鉴别特征及管理
Int J Chron Obstruct Pulmon Dis. 2024 Dec 9;19:2671-2688. doi: 10.2147/COPD.S484664. eCollection 2024.
9
Impact of medical-nursing combined policy pilot on hospitalization frequency of middle-aged and older patients with chronic diseases: a quasi-experimental study based on China Health and Retirement Longitudinal Study.医养结合政策试点对中老年慢性病患者住院频次的影响:基于中国健康与养老追踪调查的准实验研究。
Front Public Health. 2024 Oct 11;12:1450828. doi: 10.3389/fpubh.2024.1450828. eCollection 2024.
10
Coronavirus disease-19 vaccine uptake, willingness for vaccination, and associated Factors among chronic follow patients attending in the two comprehensive specialized hospitals of Bahir Dar, Ethiopia.在埃塞俄比亚巴希尔达尔的两家综合专科医院就诊的慢性病患者中,对新型冠状病毒疾病-19 疫苗的接种率、接种意愿及其相关因素。
BMC Infect Dis. 2024 Sep 13;24(1):976. doi: 10.1186/s12879-024-09882-0.
英国生物库社区队列中预测 COVID-19 和死亡率的预先存在的合并症。
J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2224-2230. doi: 10.1093/gerona/glaa183.
4
Characteristics of Persons Who Died with COVID-19 - United States, February 12-May 18, 2020.2020 年 2 月 12 日至 5 月 18 日美国因 COVID-19 去世者的特征。
MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):923-929. doi: 10.15585/mmwr.mm6928e1.
5
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
6
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
7
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.年龄和多种合并症预测 COVID-19 患者的死亡:意大利高血压学会 SARS-RAS 研究的结果。
Hypertension. 2020 Aug;76(2):366-372. doi: 10.1161/HYPERTENSIONAHA.120.15324. Epub 2020 Jun 22.
8
Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020.2019 年冠状病毒病病例监测-美国,2020 年 1 月 22 日-5 月 30 日。
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765. doi: 10.15585/mmwr.mm6924e2.
9
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.在底特律市区的一系列患者中,与 2019 年冠状病毒病相关的临床特征和发病率。
JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270.
10
Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in Seattle, Washington.华盛顿州西雅图市 105 例住院 COVID-19 患者的临床特征和结局。
Clin Infect Dis. 2020 Nov 19;71(16):2167-2173. doi: 10.1093/cid/ciaa632.